Jupiter Life Line Hospitals working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

39.66×	39.66×	36.03×	38.86×	—
14.29×	14.29×	14.34×	17.56×	18.68×
126.08×	126.08×	130.95×	119.90×	—
−72.13×	−72.13×	−80.58×	−63.48×	—
4.40×	3.27×	2.36×	3.52×	11.57×
0.70×	0.70×	0.79×	0.94×	0.91×
1.34×	1.34×	1.31×	0.65×	—
0.78×	0.78×	0.85×	0.48×	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JLHL₹260.10

Jupiter Life Line Hospitals Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH KIMS HCG MARKSANS METROPOLIS PARKHOSPS CORONAMcap ₹1,705 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Inventory Days (DIO)	—	38.86	36.03	39.66	39.66
Receivable Days (DSO)	18.68	17.56	14.34	14.29	14.29
Payable Days (DPO)	—	119.90	130.95	126.08	126.08
Cash Conversion Cycle (days)	—	-63.48	-80.58	-72.13	-72.13
Working Capital Turnover	11.57	3.52	2.36	3.27	4.40
Asset Turnover	0.91	0.94	0.79	0.70	0.70
Cash Conversion (CFO/Net Income)	—	0.65	1.31	1.34	1.34
CFO/EBITDA	—	0.48	0.85	0.78	0.78

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.